Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

13/08/2021 07:00

Aug 13 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2021        Jun 30, 2020       Mar 31, 2022  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            100 mln                               100 mln     
                                                       (-66.7 pct)   
  Operating     loss 304 mln        loss 253 mln        loss 1.30    
  Recurring     loss 306 mln        loss 253 mln        loss 1.30    
  Net           loss 306 mln        loss 253 mln        loss 1.30    
  EPS          loss 56.76 yen      loss 56.37 yen    loss 239.87 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T